Search

Search Results
Results 4731 - 4740 of 4752 for Targeted drug delivery
  • Targeting Protein Misfolding Congress 2021
    Supplier - 7 Dec 2020
    With the neurological drug market now worth $86 billion, and the FDA set to reach a decision on Biogen’s Acudanimib in Spring, whether you’re focused on oncology, Alzheimer’s or ALS, it’s an exciting...
  • Exom BioPharma, Inc.
    Supplier - 6 Sep 2024
    Exom BioPharma offers high quality research kits for exosome isolation and analysis, manufacturing highly purified exosomes from various cell lines, and animal and plant sources for research and...
  • B. Braun Melsungen AG
    Supplier - 30 Nov 2012
    B. Braun is one of the world's leading providers and manufacturers of healthcare solutions today. Every service that B. Braun provides incorporates the entirety of our knowledge and skills, the...
  • Blood-Brain Barrier Delivery Summit (B3DD)
    Supplier - 17 Jun 2019
    B3DD is a conference dedicated to addressing the translational challenges of effective and safe delivery of CNS drug candidates that cross the blood-brain barrier.
  • Ubiquigent Limited
    Supplier - 23 Jan 2023
    As pioneers in the rapidly emerging deubiquitinase (DUB) space, Ubiquigent™ is uniquely positioned to drive forward the discovery and development of novel DUB modulators as powerful new therapeutics...
  • Orbit Discovery
    Supplier - 14 Jun 2022
    Orbit develop and apply innovative drug discovery platforms defined by a unique peptide display engine that deliver novel, functional, biologically relevant peptide therapeutic leads.
  • Neurodegenerative Drug Development
    Supplier - 4 Apr 2019
    Focused on neurodegenerative disease, the drug development community will assemble at NDD Europe to overcome the translational challenges blocking the development of clinically disease modifying...
  • Neuroimmunology Drug Development
    Supplier - 4 Apr 2019
    As drug developers are investing time and money into exploring chronic neuroinflammatory targets, it is essential for the right investments to be made.
  • Hanson Wade Group - 5th Novel Conjugates Summit 2026
    Supplier - 20 Nov 2025
    Spotlighting Innovation in Novel Targeting Formats & Payloads to Enhance Delivery, Overcome Payload Resistance and Expand Therapeutic Reach
  • Hanson Wade Group - 4th Ophthalmic Drug Delivery Summit
    Supplier - 10 Nov 2025
    Innovating Patient-Centric, Longer-Lasting Delivery to Specific Ocular Targets to Strengthen Adherence to Transformative Ophthalmic Therapies with Enhanced Durability & Formulation

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback